Quest Diagnostics (DGX) Cash from Investing Activities Growth (3y) (2012 - 2026)
Quest Diagnostics (DGX) Cash from Investing Activities Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 212.62 Bn | 208.56 Bn | 8.34 Bn | 33.33% |
| 2 | Danaher | 139.22 Bn | 134.87 Bn | 3.61 Bn | -188.86% |
| 3 | Idexx Laboratories | 46.07 Bn | 45.88 Bn | 779.09 Mn | 2.46% |
| 4 | Agilent Technologies | 39.35 Bn | 37.54 Bn | 990.00 Mn | 0.00% |
| 5 | Iqvia Holdings | 38.18 Bn | 36.10 Bn | 1.44 Bn | 13.86% |
| 6 | Natera | 37.68 Bn | 36.58 Bn | 696.04 Mn | -59.07% |
| 7 | Illumina | 28.60 Bn | 27.43 Bn | 770.00 Mn | -48.84% |
| 8 | Mettler Toledo International | 28.37 Bn | 28.32 Bn | 650.22 Mn | 64.36% |
| 9 | Quest Diagnostics | 26.30 Bn | 25.67 Bn | 1.03 Bn | 41.86% |
| 10 | Labcorp Holdings | 25.82 Bn | 24.84 Bn | 1.01 Bn | -47.83% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 41.86% |
| Mar 31, 2026 | 1.28% |
| Dec 31, 2025 | -3.16% |
| Sep 30, 2025 | -19.43% |
| Jun 30, 2025 | -14.78% |
| Mar 31, 2025 | 12.04% |
| Dec 31, 2024 | -30.28% |
| Sep 30, 2024 | -157.18% |
| Jun 30, 2024 | -34.95% |
| Mar 31, 2024 | -31.82% |
| Dec 31, 2023 | 12.13% |
| Sep 30, 2023 | 17.85% |
| Jun 30, 2023 | -49.28% |
| Mar 31, 2023 | 8.46% |
| Dec 31, 2022 | -20.28% |
| Sep 30, 2022 | -2.68% |
| Jun 30, 2022 | 3.76% |
| Mar 31, 2022 | -15.39% |
| Dec 31, 2021 | 13.11% |
| Sep 30, 2021 | 8.42% |